Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair.

Standard

Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair. / Bushman, Jared; Mishra, Bibhudatta; Ezra, Mindy; Gul, Sheraz; Schulze, Christian; Chaudhury, Sidharta; Ripoll, Daniel; Wallqvist, Anders; Kohn, Joachim; Schachner, Melitta; Loers, Gabriele.

In: NEUROPHARMACOLOGY, Vol. 79, 04.2014, p. 456-466.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Bushman, J, Mishra, B, Ezra, M, Gul, S, Schulze, C, Chaudhury, S, Ripoll, D, Wallqvist, A, Kohn, J, Schachner, M & Loers, G 2014, 'Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair.', NEUROPHARMACOLOGY, vol. 79, pp. 456-466. https://doi.org/10.1016/j.neuropharm

APA

Bushman, J., Mishra, B., Ezra, M., Gul, S., Schulze, C., Chaudhury, S., Ripoll, D., Wallqvist, A., Kohn, J., Schachner, M., & Loers, G. (2014). Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair. NEUROPHARMACOLOGY, 79, 456-466. https://doi.org/10.1016/j.neuropharm

Vancouver

Bibtex

@article{8d5f2e61db1141c8986fbfa2484137d4,
title = "Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair.",
abstract = "Glycans attached to the cell surface via proteins or lipids or exposed in the extracellular matrix affect many cellular processes, including neuritogenesis, cell survival and migration, as well as synaptic activity and plasticity. These functions make glycans attractive molecules for stimulating repair of the injured nervous system. Yet, glycans are often difficult to synthesize or isolate and have the disadvantage to be unstable in a complex tissue environment. To circumvent these issues, we have screened a library of small organic compounds to search for structural and functional mimetics of the neurostimulatory glycan polysialic acid (PSA) and identified the 5-HT4 receptor agonist tegaserod as a PSA mimetic. The PSA mimicking activity of tegaserod was shown in cultures of central and peripheral nervous system cells of the mouse and found to be independent of its described function as a serotonin (5-HT4) receptor agonist. In an in vivo model for peripheral nerve regeneration, mice receiving tegaserod at the site of injury showed enhanced recovery compared to control mice receiving vehicle control as evidenced by functional measurements and histology. These data indicate that tegaserod could be repurposed for treatment of nervous system injuries and underscores the potential of using small molecules as mimetics of neurostimulatory glycans. ",
author = "Jared Bushman and Bibhudatta Mishra and Mindy Ezra and Sheraz Gul and Christian Schulze and Sidharta Chaudhury and Daniel Ripoll and Anders Wallqvist and Joachim Kohn and Melitta Schachner and Gabriele Loers",
year = "2014",
month = apr,
doi = "10.1016/j.neuropharm",
language = "English",
volume = "79",
pages = "456--466",
journal = "NEUROPHARMACOLOGY",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair.

AU - Bushman, Jared

AU - Mishra, Bibhudatta

AU - Ezra, Mindy

AU - Gul, Sheraz

AU - Schulze, Christian

AU - Chaudhury, Sidharta

AU - Ripoll, Daniel

AU - Wallqvist, Anders

AU - Kohn, Joachim

AU - Schachner, Melitta

AU - Loers, Gabriele

PY - 2014/4

Y1 - 2014/4

N2 - Glycans attached to the cell surface via proteins or lipids or exposed in the extracellular matrix affect many cellular processes, including neuritogenesis, cell survival and migration, as well as synaptic activity and plasticity. These functions make glycans attractive molecules for stimulating repair of the injured nervous system. Yet, glycans are often difficult to synthesize or isolate and have the disadvantage to be unstable in a complex tissue environment. To circumvent these issues, we have screened a library of small organic compounds to search for structural and functional mimetics of the neurostimulatory glycan polysialic acid (PSA) and identified the 5-HT4 receptor agonist tegaserod as a PSA mimetic. The PSA mimicking activity of tegaserod was shown in cultures of central and peripheral nervous system cells of the mouse and found to be independent of its described function as a serotonin (5-HT4) receptor agonist. In an in vivo model for peripheral nerve regeneration, mice receiving tegaserod at the site of injury showed enhanced recovery compared to control mice receiving vehicle control as evidenced by functional measurements and histology. These data indicate that tegaserod could be repurposed for treatment of nervous system injuries and underscores the potential of using small molecules as mimetics of neurostimulatory glycans.

AB - Glycans attached to the cell surface via proteins or lipids or exposed in the extracellular matrix affect many cellular processes, including neuritogenesis, cell survival and migration, as well as synaptic activity and plasticity. These functions make glycans attractive molecules for stimulating repair of the injured nervous system. Yet, glycans are often difficult to synthesize or isolate and have the disadvantage to be unstable in a complex tissue environment. To circumvent these issues, we have screened a library of small organic compounds to search for structural and functional mimetics of the neurostimulatory glycan polysialic acid (PSA) and identified the 5-HT4 receptor agonist tegaserod as a PSA mimetic. The PSA mimicking activity of tegaserod was shown in cultures of central and peripheral nervous system cells of the mouse and found to be independent of its described function as a serotonin (5-HT4) receptor agonist. In an in vivo model for peripheral nerve regeneration, mice receiving tegaserod at the site of injury showed enhanced recovery compared to control mice receiving vehicle control as evidenced by functional measurements and histology. These data indicate that tegaserod could be repurposed for treatment of nervous system injuries and underscores the potential of using small molecules as mimetics of neurostimulatory glycans.

U2 - 10.1016/j.neuropharm

DO - 10.1016/j.neuropharm

M3 - SCORING: Journal article

VL - 79

SP - 456

EP - 466

JO - NEUROPHARMACOLOGY

JF - NEUROPHARMACOLOGY

SN - 0028-3908

ER -